Tag Archives: BioSpace

Deep learning predicts a woman’s risk of breast cancer

[ad_1] OAK BROOK, Ill., November 30, 2020 / PRNewswire / – Massachusetts General Hospital (MGH) researchers have developed a deep learning model that identifies imaging biomarkers on mammography screening to predict a patient’s risk of developing breast cancer more accurately than traditional assessment tools risk. The results of the study …

Read More »

Discovery of potential treatment against antibiotic-resistant bacteria that cause gonorrhea and meningitis

[ad_1] MONTREAL is LAVAL, November 24, 2020 / CNW Telbec / – A team from National Institute for Scientific Research (INRS) demonstrated the effectiveness of an inexpensive molecule to fight antibiotic-resistant strains of the bacteria responsible for gonorrhea and meningococcal meningitis. These two infections affect millions of people around the …

Read More »

Innovent announces Phase I clinical trial results of IBI302, a first-class anti-VEGF and anti-complement ophthalmic recombinant human bi-specific fusion protein for age-related neovascular macular degeneration at 2020 AAO

[ad_1] SAN FRANCISCO and SUZHOU, China, November 15, 2020 / PRNewswire / – Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and markets high-quality medicines for the treatment of oncological, metabolic, autoimmune and other major diseases, announces that the results of Phase Clinical I The …

Read More »

SSRI antidepressants may be effective early treatments for COVID-19

[ad_1] Researchers at Washington University School of Medicine in St. Louis published the results of a clinical trial evaluating an antidepressant, fluvoxamine, for early treatment for COVID-19. The study was published in JAMA, The Journal of the American Medical Association, and was funded by the COVID-19 Early Treatment Fund (CETF). …

Read More »